JORDYN LEWIS: Open Payments
NPI 1225737752 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,026 in 101 payments from 28 companies in 2025. Trend: 2023 $1,283 · 2024 $1,113 · 2025 $2,026
Food & beverage: $2,026
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $300 |
| Amgen Inc. | 12 | $204 |
| Vanda Pharmaceuticals Inc. | 7 | $180 |
| Phathom Pharmaceuticals, Inc. | 3 | $167 |
| Lilly USA, LLC | 10 | $157 |
| E.R. Squibb & Sons, L.L.C. | 1 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Corcept Therapeutics | 3 | $67 |
Products named: VRAYLAR, FANAPT, VOQUEZNA, REPATHA, COBENFY, CAPLYTA, OTEZLA, XIFAXAN.
Industry payments across GA — which companies pay providers there.
